These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9565444)

  • 1. School-age follow-up of prophylactic versus rescue surfactant trial: pulmonary, neurodevelopmental, and educational outcomes.
    Sinkin RA; Kramer BM; Merzbach JL; Myers GJ; Brooks JG; Palumbo DR; Cox C; Kendig JW; Mercier CE; Phelps DL
    Pediatrics; 1998 May; 101(5):E11. PubMed ID: 9565444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal, 15-year follow-up of children born at less than 29 weeks' gestation after introduction of surfactant therapy into a region: neurologic, cognitive, and educational outcomes.
    D'Angio CT; Sinkin RA; Stevens TP; Landfish NK; Merzbach JL; Ryan RM; Phelps DL; Palumbo DR; Myers GJ
    Pediatrics; 2002 Dec; 110(6):1094-102. PubMed ID: 12456905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
    Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
    J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant.
    Vaucher YE; Harker L; Merritt TA; Hallman M; Gist K; Bejar R; Heldt GP; Edwards D; Pohjavuori M
    J Pediatr; 1993 Jan; 122(1):126-32. PubMed ID: 8419599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of neonatal surfactant therapy on lung function at school age in children born very preterm.
    Pelkonen AS; Hakulinen AL; Turpeinen M; Hallman M
    Pediatr Pulmonol; 1998 Mar; 25(3):182-90. PubMed ID: 9556010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: results of a double-blind trial. American Exosurf Neonatal Study Group I.
    Walther FJ; Mullett M; Schumacher R; Sundell H; Easa D; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S13-9. PubMed ID: 7745506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation.
    Kendig JW; Notter RH; Cox C; Reubens LJ; Davis JM; Maniscalco WM; Sinkin RA; Bartoletti A; Dweck HS; Horgan MJ
    N Engl J Med; 1991 Mar; 324(13):865-71. PubMed ID: 2000109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
    Sell M; Cotton R; Hirata T; Guthrie R; LeBlanc M; Mammel M; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S20-5. PubMed ID: 7745507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. School-age follow-up of a single-dose prophylactic surfactant cohort.
    Wagner CL; Kramer BM; Kendig JW; Brooks JG; Cox C; Wagner MT; Phelps DL
    J Dev Behav Pediatr; 1995 Oct; 16(5):327-32. PubMed ID: 8557832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial.
    Kendig JW; Ryan RM; Sinkin RA; Maniscalco WM; Notter RH; Guillet R; Cox C; Dweck HS; Horgan MJ; Reubens LJ; Risemberg H; Phelps DL
    Pediatrics; 1998 Jun; 101(6):1006-12. PubMed ID: 9606227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health and developmental outcomes of a surfactant controlled trial: follow-up at 2 years.
    Ware J; Taeusch HW; Soll RF; McCormick MC
    Pediatrics; 1990 Jun; 85(6):1103-7. PubMed ID: 1692612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine Surfactant Replacement Therapy in Neonates of Less than 32 Weeks' Gestation: A Multicenter Controlled Trial of Prophylaxis versus Early Treatment in China--a Pilot Study.
    Kong X; Cui Q; Hu Y; Huang W; Ju R; Li W; Wang R; Xia S; Yu J; Zhu T; Feng Z
    Pediatr Neonatol; 2016 Feb; 57(1):19-26. PubMed ID: 26059103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health and neurodevelopmental outcome at 1-year adjusted age in 508 infants weighing 700 to 1100 grams who received prophylaxis with one versus three doses of synthetic surfactant. American Exosurf Neonatal Study Groups I and II.
    Gerdes J; Gerdes M; Beaumont E; Cook L; Dhanireddy R; Kopleman A; Jarret R; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S26-32. PubMed ID: 7745508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue.
    Bevilacqua G; Parmigiani S;
    J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2000; (2):CD000510. PubMed ID: 10796379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll RF; Wiswell T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.